Ajanta Pharma launches eletriptan hydrobromide tabs

Eletriptan hydrobromide tabs are indicated to treat headache

Ajanta Pharma has launched eletriptan hydrobromide tablets, used to treat headache, in the US market.

“It is a bioequivalent generic version of Relpax tablets. Ajanta Pharma has launched the product in two strengths, 20 mg and 40 mg tablets,” the company said in a BSE filing.

Eletriptan hydrobromide tablets, the company said, is a part of its growing portfolio of products developed for the US market.

Ajanta has 35 Abbreviated New Drug Applications (ANDAs) of which it has 19 final ANDA approvals, two tentative approvals, and 14 ANDAs under review with US FDA. So far it has launched 14 products in the US market.